Multi-omic derived cell-type specific Alzheimer disease polygenic risk scores
Nicholas O'Neill1, Nuzulul Kurniansyah1, Congcong Zhu2
1Bioinformatics Program, Boston University, Boston, MA, USA; Departments of Medicine (Section of Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Neurobiology of Aging
|July 24, 2025
Summary
Alzheimer disease polygenic risk scores (ADPRS) built using single-nuclei ATAC-seq data show higher cell-type specificity than those from single-nuclei RNA-seq. These scores link specific cell types, like astrocytes and microglia, to AD endophenotypes, with NPY variants strongly associated with SST+ GABAergic neuron ADPRS.
Area of Science:
- Neuroscience
- Genetics
- Computational Biology
Background:
- Alzheimer disease (AD) pathogenesis involves complex genetic factors influencing various cell types in the brain.
- Polygenic risk scores (PRS) are valuable tools for dissecting genetic contributions to complex diseases.
- Cell-type specific PRS (ct-PRS) can offer higher resolution in understanding disease mechanisms.
Purpose of the Study:
- To develop and compare cell-type specific Alzheimer disease polygenic risk scores (ct-ADPRSs) using single-nuclei RNA-seq (snRNA) and single-nuclei ATAC-seq (snATAC) data.
- To investigate the cell-type specificity of these ct-ADPRSs.
- To associate ct-ADPRSs with AD endophenotypes, including tau tangle burden, neuritic plaque burden, and cognitive scores.
Main Methods:
- Derived ct-ADPRSs utilizing genetic variants near cell-type specific genes from snRNA and accessible chromatin regions from snATAC.
- Generated a multi-omic ct-ADPRS for eight neuron subtypes.
- Assessed cell-type specificity by calculating correlations among ct-ADPRSs.
- Evaluated associations with AD endophenotypes using logistic and linear regression models.
Main Results:
- snATAC-derived ct-ADPRSs exhibited significantly lower inter-cell-type correlations (average r=0.071) compared to snRNA-derived ct-ADPRSs (average r=0.19), indicating superior cell-type specificity.
- Tau tangle burden associated with astrocyte (AST) and microglia (MIC) ct-ADPRSs from both snATAC and snRNA.
- AST ct-ADPRS from snATAC uniquely associated with Mini-Mental State Examination score.
- SST+ GABAergic neuron ct-ADPRS strongly associated with neuritic plaque burden and was the only neuron subtype ct-ADPRS significantly linked to AD endophenotypes.
- Variants upstream of the Neuropeptide Y (NPY) gene, particularly rs3940268, showed the strongest association with the SST+ GABAergic neuron ct-ADPRS.
Conclusions:
- snATAC-derived ct-ADPRSs provide enhanced cell-type specificity for dissecting AD genetic architecture.
- Specific cell types, including astrocytes, microglia, and SST+ GABAergic neurons, play distinct roles in AD pathology.
- Genetic variants near the NPY gene may significantly influence AD risk through their impact on SST+ GABAergic neurons.
Keywords:
Alzheimer diseaseAmyloid pathologyPolygenic risk scoresSomatostatinneuropeptide YsnATAC-seqMore Related Videos
Related Concept Videos
Polygenic Traits
66.5K
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
66.5K
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Genome-wide Association Studies-GWAS
14.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.2K


